Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in icelandic multicase systemic lupus erythematosus families

Arthritis and Rheumatism

Volumn 58, Issue 12, 2008, Pages 3865-3872

  Kristjansdottir, Helga ^a,b   Saevarsdottir, Saedis ^a,c   Gröndal, Gerdur ^a   Alarcón Riquelme, Marta E ^b   Erlendsson, Kristjan ^a   Valdimarsson, Helgi ^a   Steinsson, Kristjan ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; MANNAN BINDING LECTIN;

ADULT; ALLELE; ALLOTYPE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; C4AQ0 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELECTROPHORESIS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; MALE; PD 1.3A GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMPLEMENT C4A; EPISTASIS, GENETIC; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ICELAND; LUPUS ERYTHEMATOSUS, SYSTEMIC; MANNOSE-BINDING LECTIN;

EID: 57349091732     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24129     Document Type: Article

References (47)

1. Alarcon-Segovia D, Alarcon-Riquelme ME. Etiopathogenesis of systemic lupus erythematosus: the itineraries of three troikas. In: Lahita RG, editor. Systemic lupus erythematosus. San Diego, CA: Elsevier Academic Press; 2003. p. 55-65.
2. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
3. Kristjansdottir H, Bjarnadottir K, Hjalmarsdottir IB, Grondal G, Arnason A, Steinsson K. A study of C4AQ0 and MHC haplotypes in Icelandic multicase families with systemic lupus erythematosus. J Rheumatol 2000;27:2590-6.
4. Kristjansdottir H, Steinsson K. A study of the genetic basis of C4A protein deficiency: detection of C4A gene deletion by long-range PCR and its associated haplotypes. Scand J Rheumatol 2004;33:417-22.
5. Steinsson K, Jonsdottir S, Arason GJ, Kristjansdottir H, Fossdal R, Skaftadottir I, et al. A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland. Ann Rheum Dis 1998;57:503-5.
6. Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01,DR17]. J Rheumatol 1995;22:1852-61.
7. Saevarsdottir S, Kristjansdottir H, Grondal G, Vikingsdottir T, Steinsson K, Valdimarsson H. Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus. Ann Rheum Dis 2006;65:1462-7.
8. Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus. J Rheumatol 2002;29:2359-66.
9. Lindqvist AK, Steinsson K, Johanneson B, Kristjansdottir H, Arnasson A, Grondal G, et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000;14:169-78.
10. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002;32:666-9.
11. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006;27:195-201.
12. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-48.
13. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007;8:239-45.
14. Alarcon GS, Beasley TM, Roseman JM, McGwin G Jr, Fessler BJ, Bastian HM, et al, LUMINA Study Group. Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). Lupus 2005;14:867-8.
15. Steinsson K, Alarcon-Riquelme ME. Genetic aspects of rheumatic diseases. Scand J Rheumatol 2005;34:167-77.
16. Gregersen PK, Behrens TW. Genetics of autoimmune diseases - disorders of immune homeostasis. Nat Rev Genet 2006;7:917-28.
17. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A 1998;95:9979-84.
18. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002;169:5-9.
19. Myerscough A, John S, Barrett JH, Ollier WE, Worthington J. Linkage of rheumatoid arthritis to insulin-dependent diabetes mellitus loci: evidence supporting a hypothesis for the existence of common autoimmune susceptibility loci. Arthritis Rheum 2000;43:2771-5.
20. Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004;50:2590-7.
21. Thorburn CM, Prokunina-Olsson L, Sterba KA, Lum RF, Seldin MF, Alarcon-Riquelme ME, et al. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007;8:279-87.
22. Prokunina L, Padyukov L, Bennet A, de Faire U, Wiman B, Prince J, et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004;50:1770-3.
23. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003;62:492-7.
24. Anaya JM, Gomez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol 2006;13:185-95.
25. Steinsson K, Arnason A, Erlendsson K, Fossdal R, Skaftadottir I, Jonsdottir S, et al. A study of the major histocompatibility complex in a Caucasian family with multiple cases of systemic lupus erythematosus: association with the C4AQ0 phenotype. J Rheumatol 1995;22:1862-6.
26. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
27. Grant SF, Kristjansdottir H, Steinsson K, Blondal T, Yuryev A, Stefansson K, et al. Long PCR detection of the C4A null allele in B8-C4AQ0-C4B1-DR3. J Immunol Methods 2000;244:41-7.
28. Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis: a prospective study. J Rheumatol 2001;28:728-34.
29. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000;241:33-42.
30. Corporaal S, Bijl M, Kallenberg CG. Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol 2002;21:108-13.
31. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, et al, on behalf of the Grupo Latino-americano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138-47.
32. Giles I, Isenberg D. Antinuclear antibodies: an overview. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 418.
33. Laustrup H, Heegaard NH, Voss A, Green A, Lillevang ST, Junker P. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus 2004;13:792-9.
34. Ramos PS, Kelly JA, Gray-McGuire C, Bruner GR, Leiran AN, Meyer CM, et al. Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun 2006;7:417-32.
35. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43.
36. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun 2007;29:1-9.
37. Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr Opin Immunol 2000;12:691-7.
38. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003;35:349-56.
39. Krishnan S, Chowdhury B, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006;18:230-43.
40. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 2005;50:264-6.
41. Turpeinen H, Laine AP, Hermann R, Simell O, Veijola R, Knip M, et al. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur J Immunogenet 2003;30:289-93.
42. Saevarsdottir S, Steinsson K, Grondal G, Valdimarsson H. Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls. J Rheumatol 2007;34:1692-5.
43. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-37.
44. Abelson AK, Johansson CM, Kozyrev SV, Kristjansdottir H, Gunnarsson I, Svenungsson E, et al. No evidence of association between genetic variants of the PDCD1 ligands and SLE. Genes Immun 2007;8:69-74.
45. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
46. Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003;33:2853-63.
47. Traustadottir KH, Steinsson K, Erlendsson K. C4AQ0 superimposed on a primary defect increases the susceptibility to systemic lupus erythematosus (SLE) in a family with association between C4AQ0 and SLE. J Rheumatol 1998;25:2118-25.